ATLASQuest Diagnostics (DGX) Q3 2026 earnings results
Quest Diagnostics (DGX) reported EPS of $3.00 against an analyst estimate of $2.85: a beat of $0.15 (5.3%). The quarter ended Sep 30, 2026; the company reported on Thursday, October 22, 2026, before the open.
Status: Confirmed · cross-checked Nov 2 · Source: EODHD (calendar and fundamentals, cross-checked)
Notify me when Quest Diagnostics reports
Track DGX free Add Quest Diagnostics to a free ATLAS watchlist.
DGX Q3 2026 results at a glance
| EPS reported | $3.00 |
|---|---|
| EPS estimate | $2.85 |
| Surprise | Beat · +$0.15 (+5.3%) |
| Quarter ended | Sep 30, 2026 |
| Reported | Oct 22, 2026, before the open |
| Status | Confirmed · cross-checked Nov 2 |
EPS is as supplied by EODHD, in US dollars per share; whether it is adjusted or GAAP follows that source. This is Quest Diagnostics’s Q3 2026, a calendar-year company.
Quest Diagnostics EPS surprise history: last 3 quarters
Quest Diagnostics beat the EPS estimate in 3 of its last 3 reports, with an average surprise of +11.4%.
| Report date | EPS est. | EPS actual | Surprise | Result | Move* |
|---|---|---|---|---|---|
| Oct 22, 2026 | $2.85 | $3.00 | +5.3% | Beat | +1.2% |
| Jul 23, 2026 | $2.82 | $3.12 | +10.6% | Beat | +8.6% |
| May 8, 2026 | $0.11 | $0.13 | +18.2% | Beat | -0.5% |
*Move: change in the closing price from the last close before the report day to the close the day after it. It is filled in a few trading days after each report.
DGX stock reaction to the report
DGX moved +1.82% in the first session that reflects the report (close of Oct 21, 2026 $238.93 to close of Oct 22, 2026 $243.28). Since the report: +4.97% (latest close $250.81 on Nov 2, 2026, against $238.93 before the reaction).
Next DGX earnings report
Quest Diagnostics has not announced its next earnings date yet. This page shows a date only once it is confirmed. See the DGX earnings calendar.
ATLAS fair value and signal for DGX
| Last price | $251.82 (-0.4%) |
|---|---|
| ATLAS fair value | $284.18 (range $222.30–$363.29) · price is 11% below it |
| Chance of a higher close in 1 month | 53% (normal range $243.31–$262.61) |
These are model outputs from the same valuation and calibrated model as the Quest Diagnostics stock page. They describe an ordinary period and are not a forecast of any particular outcome.
Quest Diagnostics Q3 2026 earnings: frequently asked questions
Did Quest Diagnostics beat earnings estimates for Q3 2026?
Quest Diagnostics reported EPS of $3.00 against an analyst estimate of $2.85: a beat of $0.15 (5.3%).
When did Quest Diagnostics report Q3 2026 results?
Quest Diagnostics reported on Thursday, October 22, 2026, before the open, for the quarter ended Wednesday, September 30, 2026.
How often does DGX beat EPS estimates?
In its last 3 reports with a recorded result, Quest Diagnostics beat the EPS estimate 3 times; the average surprise was +11.4%. Past results do not predict the next one.
How does ATLAS confirm a result?
A result is published only after it is cross-checked: the EODHD earnings calendar and the EODHD fundamentals feed must show the same EPS for the same fiscal period, or the same value must appear in two consecutive checks. Unconfirmed figures are never published. If the figures are revised later, this page updates.
Educational information, not investment advice. Disclaimer